Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug, giving the drugs in different
ways, and combining biological therapy with chemotherapy may kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of topotecan, paclitaxel, and carboplatin
with or without filgrastim in treating patients who have advanced solid tumor or lymphoma
that has not responded to standard therapy.